Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H22O10S2 |
InChIKeyLJBKHHZPVCABCX-ZYUZMQFOSA-N |
CAS Registry71240-74-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | - | - |